Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastro-esophageal reflux disease.

B Joelsson1

  • 1Department of Surgery, Värnamo Hospital, Sweden.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1988
PubMed
Summary

Gastro-esophageal reflux disease (GERD) occurs when stomach contents flow back into the esophagus, causing symptoms or damage. Treatment timing may be more effective in the evening due to reflux patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.

Alimentary pharmacology & therapeutics·2000
Same author

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.

Archives of internal medicine·2000
Same author

Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.

Alimentary pharmacology & therapeutics·1999
Same author

Determining the cost of gastroesophageal reflux disease: a decision analytic model.

The American journal of managed care·1999
Same author

High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.

The American journal of gastroenterology·1999
Same author

Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire.

Alimentary pharmacology & therapeutics·1993

Area of Science:

  • Gastroenterology
  • Digestive Health
  • Esophageal Physiology

Background:

  • Gastro-esophageal reflux (GER) involves stomach contents entering the esophagus.
  • Reflux-like dyspepsia and reflux esophagitis are key clinical and pathological manifestations.
  • Pathologic GER is defined by intraesophageal acid exposure exceeding 5% of monitoring time.

Purpose of the Study:

  • To define gastro-esophageal reflux disease (GERD) based on symptoms and esophageal damage.
  • To evaluate the timing of esophageal acid exposure throughout a 24-hour period.
  • To inform optimal timing for GERD treatment strategies.

Main Methods:

  • Utilized intraesophageal pH-monitoring to quantify acid exposure.
  • Defined pathologic GER based on established acid exposure thresholds.
  • Analyzed temporal patterns of esophageal acid exposure.

Main Results:

  • Esophageal acid exposure peaks in the evening and is minimal after midnight.
  • GERD is diagnosed when reflux causes symptoms or esophagitis.
  • 'Columnar lined esophagus' is preferred over 'Barret's esophagus' terminology.

Conclusions:

  • GERD diagnosis requires correlating reflux events with symptoms or esophagitis.
  • Understanding the diurnal pattern of acid reflux suggests evening-focused treatment may be beneficial.
  • Optimizing treatment timing could improve patient outcomes for GERD.

Related Experiment Videos